ArticleCureus2025
Association Between Longitudinal Changes in Cardio-Ankle Vascular Index and Aortic Stenosis Progression in Dialysis Patients: A Retrospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective In dialysis patients, echocardiography often underestimates the progression of aortic stenosis (AS) due to blood pressure fluctuations and extensive calcification that obscure standard indices. We evaluated whether serial changes in the cardio-ankle vascular index (CAVI), a blood pressure-independent marker of arterial stiffness, can anticipate severe AS and guide the timing of valve replacement. Methods This single-center, retrospective study screened 1,169 maintenance dialysis patients (2015-2023). Forty-one patients who underwent surgical or transcatheter aortic valve replacement (AVR/TAVR) had valid CAVI measurements at four time points: 2 years and 1 year before surgery, immediately before surgery, and 1 year after surgery. The -2-year time point served as the baseline. Hemodynamic, echocardiographic, and laboratory data were analyzed using the Friedman and Wilcoxon tests. Severe AS progression was defined as a new mean pressure gradient (meanPG) ≥ 40 mmHg. Determinants of progression were identified using multivariable logistic regression. Results Median CAVI declined from 10.2 to 9.4 over the two years preceding surgery (p < 0.001) and rose to 11.1 one year post-AVR/TAVR (p < 0.001). Simultaneously, ejection time increased, ejection fraction decreased, and Vmax, maxPG, stroke volume, and stroke volume index (SVi) all rose significantly (p < 0.01 for each), with no significant changes in blood pressure or heart rate. Patients who progressed to severe AS showed a greater CAVI decline (ΔCAVI -2.90 vs. -0.67; p = 0.022) and higher Vmax (4.0 vs. 3.0 m/s; p < 0.001). ΔCAVI was the only independent predictor of severe AS progression (OR 0.51 per 1-unit decrease; 95% CI: 0.20-0.89; p = 0.013). Age and sex were not significant. CAVI and peak PG showed a modest inverse correlation (ρ = -0.35). Conclusion In dialysis patients, a marked preoperative decline in CAVI nearly doubles the risk of emergent severe AS and normalizes after valve replacement, indicating true hemodynamic responsiveness. Serial CAVI monitoring, simple, noninvasive, and reproducible, may offer an early warning signal and help optimize intervention timing when echocardiographic findings are ambiguous.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.